Investing.com - Neogen reported on Tuesday first quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Neogen announced earnings per share of $0.05 on revenue of $132.35M. Analysts polled by Investing.com anticipated EPS of $0.13 on revenue of $135.74M.
Neogen shares are down 68% from the beginning of the year and are trading at $14.26 , down-from-52-week-high.
Neogen follows other major Healthcare sector earnings this month
Neogen's report follows an earnings beat by Merck ADR on Friday, September 9, 2022, who reported EPS of $0.5392 on revenue of $5.69B, compared to forecasts EPS of $0.5165 on revenue of $5.57B.
Veeva Systems A had beat expectations on Wednesday, August 31, 2022 with second quarter EPS of $1.03 on revenue of $534.22M, compared to forecast for EPS of $1.01 on revenue of $530.71M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar